Skip to main content
Erschienen in: World Journal of Urology 12/2017

10.07.2017 | Original Article

Implementation of minimally invasive percutaneous nephrolithotomy (MIP): comparison of the initial learning curve with the later on clinical routine in a tertiary centre

verfasst von: T. Bergmann, T. R. W. Herrmann, Th. Schiller, U. Zimmermann, M. Burchardt

Erschienen in: World Journal of Urology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

We report on the comparison of clinical results of the early phase of implementation of minimally invasive PNL (MIP) in a mentor-based approach with the later on clinical routine in a tertiary centre.

Patients and methods

From January 2010 until January 2015 MIP was performed in 190 patients. Stone and patient characteristics were recorded in prospective manner. Perioperative complications were recorded within the Clavien-Classification. The first 120 consecutive patients undergoing MIP were evaluated and divided into three groups of 40 patients each. Mentor-based introduction of MIP was done within the first 40 patients (group A). Further patients were treated on routine clinical practice basis (group B and C). Treatment outcome was compared within the three groups.

Results

The groups did not significantly differ with regard to patient characteristics, operation time and decline in haemoglobin. In the mentor-based series mean stone size was 21.7 ± 12.6 vs. 15.6 ± 7.9 and 16.1 ± 8.4 mm in group B and C (p = 0.033). Primary stone-free rates were 65, 87.5 and 87.5% for the three groups (p = 0.015). Stone-free rate was higher in smaller and simple stones. Overall, complication rate was 41.7% including 36.7% Clavien grade I and II complications.

Conclusions

MIP can be implemented safe and effectively with mentor-based approach. MIP has a high safety profile, which allows high safety and efficacy of MIP at the time of implementation.
Literatur
1.
Zurück zum Zitat Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51(4):899–906 (discussion 906) CrossRefPubMed Michel MS, Trojan L, Rassweiler JJ (2007) Complications in percutaneous nephrolithotomy. Eur Urol 51(4):899–906 (discussion 906) CrossRefPubMed
2.
Zurück zum Zitat Kukreja R et al (2004) First prize: factors affecting blood loss during percutaneous nephrolithotomy: Prospective Study. J Endourol 18(8):715–722CrossRefPubMed Kukreja R et al (2004) First prize: factors affecting blood loss during percutaneous nephrolithotomy: Prospective Study. J Endourol 18(8):715–722CrossRefPubMed
4.
Zurück zum Zitat Nagele U et al. (2008) Minimally invasive percutaneous nephrolitholapaxy (MIP). Urologe A 47(9):1066, 1068–73 Nagele U et al. (2008) Minimally invasive percutaneous nephrolitholapaxy (MIP). Urologe A 47(9):1066, 1068–73
5.
Zurück zum Zitat Lahme S et al (2001) Minimally invasive PCNL in patients with renal pelvic and calyceal stones. Eur Urol 40(6):619–624CrossRefPubMed Lahme S et al (2001) Minimally invasive PCNL in patients with renal pelvic and calyceal stones. Eur Urol 40(6):619–624CrossRefPubMed
6.
Zurück zum Zitat Nagele U et al (2008) Management of lower-pole stones of 0.8–1.5 cm maximal diameter by the minimally invasive percutaneous approach. J Endourol 22(9):1851–1853 (discussion 1857) CrossRefPubMed Nagele U et al (2008) Management of lower-pole stones of 0.8–1.5 cm maximal diameter by the minimally invasive percutaneous approach. J Endourol 22(9):1851–1853 (discussion 1857) CrossRefPubMed
9.
Zurück zum Zitat Zeng G et al (2013) Minimally invasive percutaneous nephrolithotomy for simple and complex renal caliceal stones: a comparative analysis of more than 10,000 cases. J Endourol 27(10):1203–1208CrossRefPubMedPubMedCentral Zeng G et al (2013) Minimally invasive percutaneous nephrolithotomy for simple and complex renal caliceal stones: a comparative analysis of more than 10,000 cases. J Endourol 27(10):1203–1208CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Schilling D et al (2011) The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert. World J Urol 29(6):749–753CrossRefPubMed Schilling D et al (2011) The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert. World J Urol 29(6):749–753CrossRefPubMed
11.
Zurück zum Zitat de la Rosette JJ et al (2008) Training in percutaneous nephrolithotomy–a critical review. Eur Urol 54(5):994–1001CrossRefPubMed de la Rosette JJ et al (2008) Training in percutaneous nephrolithotomy–a critical review. Eur Urol 54(5):994–1001CrossRefPubMed
12.
Zurück zum Zitat Ziaee SA et al (2010) Evaluation of the learning curve for percutaneous nephrolithotomy. Urol J 7(4):226–231PubMed Ziaee SA et al (2010) Evaluation of the learning curve for percutaneous nephrolithotomy. Urol J 7(4):226–231PubMed
13.
Zurück zum Zitat Tefekli A et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53(1):184–190CrossRefPubMed Tefekli A et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53(1):184–190CrossRefPubMed
14.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Fernstrom I, Johansson B (1976) Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 10(3):257–259CrossRefPubMed Fernstrom I, Johansson B (1976) Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 10(3):257–259CrossRefPubMed
16.
Zurück zum Zitat Mishra S et al (2011) Prospective comparative study of miniperc and standard PNL for treatment of 1–2 cm size renal stone. BJU Int 108(6):896–899 (discussion 899–900) PubMed Mishra S et al (2011) Prospective comparative study of miniperc and standard PNL for treatment of 1–2 cm size renal stone. BJU Int 108(6):896–899 (discussion 899–900) PubMed
17.
Zurück zum Zitat Abdelhafez MF et al (2013) Minimally invasive percutaneous nephrolithotomy: a comparative study of the management of small and large renal stones. Urology 81(2):241–245CrossRefPubMed Abdelhafez MF et al (2013) Minimally invasive percutaneous nephrolithotomy: a comparative study of the management of small and large renal stones. Urology 81(2):241–245CrossRefPubMed
18.
Zurück zum Zitat Abdelhafez MF et al (2016) Minimally invasive versus conventional large-bore percutaneous nephrolithotomy in the treatment of large-sized renal calculi: surgeon’s preference? Scand J Urol 50(3):212–215CrossRefPubMed Abdelhafez MF et al (2016) Minimally invasive versus conventional large-bore percutaneous nephrolithotomy in the treatment of large-sized renal calculi: surgeon’s preference? Scand J Urol 50(3):212–215CrossRefPubMed
19.
Zurück zum Zitat Tefekli A, Cordeiro E, de la Rosette JJ (2013) An update on percutaneous nephrolithotomy: lessons learned from the CROES PCNL Global Study. Minerva Med 104(1):1–21PubMed Tefekli A, Cordeiro E, de la Rosette JJ (2013) An update on percutaneous nephrolithotomy: lessons learned from the CROES PCNL Global Study. Minerva Med 104(1):1–21PubMed
20.
Zurück zum Zitat Cheng F et al (2010) Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol 24(10):1579–1582CrossRefPubMed Cheng F et al (2010) Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol 24(10):1579–1582CrossRefPubMed
21.
Zurück zum Zitat Kukreja R et al (2004) Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 18(8):715–722CrossRefPubMed Kukreja R et al (2004) Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 18(8):715–722CrossRefPubMed
22.
Zurück zum Zitat Abdelhafez MF et al (2012) Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones. BJU Int 110(11):E1022–E1026CrossRefPubMed Abdelhafez MF et al (2012) Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones. BJU Int 110(11):E1022–E1026CrossRefPubMed
23.
Zurück zum Zitat Fuller A et al (2012) The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol 188(1):138–144CrossRefPubMed Fuller A et al (2012) The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol 188(1):138–144CrossRefPubMed
24.
Zurück zum Zitat Opondo D et al (2012) Impact of case volumes on the outcomes of percutaneous nephrolithotomy. Eur Urol 62(6):1181–1187CrossRefPubMed Opondo D et al (2012) Impact of case volumes on the outcomes of percutaneous nephrolithotomy. Eur Urol 62(6):1181–1187CrossRefPubMed
Metadaten
Titel
Implementation of minimally invasive percutaneous nephrolithotomy (MIP): comparison of the initial learning curve with the later on clinical routine in a tertiary centre
verfasst von
T. Bergmann
T. R. W. Herrmann
Th. Schiller
U. Zimmermann
M. Burchardt
Publikationsdatum
10.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-017-2069-6

Weitere Artikel der Ausgabe 12/2017

World Journal of Urology 12/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.